Study to Assess Safety, Tolerability and Pharmacokinetics of XC221 in Healthy Volunteers
Clinical trial NCT03459391 · COMPLETED
Trial details
- NCT number
- NCT03459391
- Sponsor
- PHARMENTERPRISES LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-22
- Primary completion
- 2017-09-26
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.